Skip to content

Clinical trials

Observational Head and Neck Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Head and Neck Neoplasms Phase: Observational Clear all

512 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20014
20023
20036
200410
200514
200617
200716
200815
200914
201011
201112
201219
201314
201413
201525
201619
201722
201823
201926
202031
202130
202232
202333
202433
202540
202621

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed237
Recruiting97
Unknown status84
Terminated30
Not yet recruiting24
Active, not recruiting21
Withdrawn14
Enrolling by invitation4
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center18
Memorial Sloan Kettering Cancer Center14
Vanderbilt-Ingram Cancer Center14
Chang Gung Memorial Hospital13
Royal Marsden NHS Foundation Trust11
University Health Network, Toronto11
Mayo Clinic9
Stanford University9
Vanderbilt University Medical Center8
European Institute of Oncology6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Head and Neck Neoplasms512
Squamous Cell Carcinoma of Head and Neck75
Lung Neoplasms63
Breast Neoplasms51
Neoplasms44
Prostatic Neoplasms31
Esophageal Neoplasms30
Melanoma29
Salivary Gland Neoplasms29
Carcinoma, Squamous Cell28

Trials

Showing 1 to 25 of 512. Each trial links to its page on Pharma Observatory.

412 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.